Soleno Therapeutics Inc. (SLNO) Declined -6.63% or -0.13 To Price $1.83 On Thursday

Soleno Therapeutics Inc. (SLNO) declined -6.63% or -0.13 to $1.83. It is close to 70922 shares traded, which is 313.34% compare to the average total volume 22634. The market cap of SLNO is $39.19 million. The year to date change is 0.47%. The 52 week price range is from $1.32 to $3.6. Price of SLNO have changed -14.04% during last week. It have changed -9.68% over last month, -36.16% over last 3 months, 8.89% over last 6 months and -17.65% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for SLNO is 2.25. It is 22.95% above current price. The 200-day Moving Averages for SLNO is 2.06. It is 12.57% above current price. The 52-week High is 3.6. It is 96.72% from the current price. The 52-week Low is 1.32. It is -27.87% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of SLNO is 3.13 on 2018-09-28. Short % to float is 0.38%. There are some statistics of SLNO. It is has market cap $39.19 million. The share outstanding is 21.41 million. The average volume is 22634. The percent of top 15 Institution holding is 70.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of SLNO is -93.68%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of SLNO is -62.73%.


Share this post